Atossa Therapeutics, Inc. Common Stock ATOS

$2.79 +7.31% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-08-07 View →
10-Q 10-Q 2026-08-07 View →
424B5 424B5 2026-06-12 View →
8-K 8-K 2026-06-11 View →
4 4 2026-05-14 View →
4 4 2026-05-14 View →
4 4 2026-05-14 View →
4 4 2026-05-14 View →
4 4 2026-05-14 View →
4 4 2026-05-14 View →
8-K 8-K 2026-05-08 View →
10-Q 10-Q 2026-05-08 View →
8-K 8-K 2026-05-08 View →
8-K 8-K 2026-04-16 View →
4 4 2026-03-31 View →
4 4 2026-03-30 View →
DEF 14A DEF 14A 2026-03-30 View →
10-K 10-K 2026-03-25 View →
8-K 8-K 2026-03-25 View →
8-K 8-K 2026-02-20 View →
424B5 424B5 2026-02-20 View →
8-K 8-K 2026-02-17 View →
8-K 8-K 2026-02-11 View →
8-K 8-K 2026-01-26 View →
4 4 2026-01-22 View →
8-K 8-K 2026-01-09 View →
8-K 8-K 2026-01-06 View →
DEF 14A DEF 14A 2025-12-22 View →
8-K 8-K 2025-12-04 View →
10-Q 10-Q 2025-11-12 View →
8-K 8-K 2025-11-12 View →
4 4 2025-10-21 View →
8-K 8-K 2025-10-14 View →
8-K 8-K 2025-09-26 View →
8-K 8-K 2025-09-08 View →
8-K 8-K 2025-08-21 View →
10-Q 10-Q 2025-08-12 View →
8-K 8-K 2025-08-12 View →
4 4 2025-05-22 View →
4 4 2025-05-16 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$2.79
Market Cap
$25.95 million
52-Week Range
$1.70 – $19.35
Average Volume
87K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.